Related Experiment Video
Updated: Mar 24, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae
Anne-Pauline Bellanger1, Alexander M Tatara1, Fazal Shirazi1
1Department of Infectious Disease, Infection Control, and Employee Health, University of Texas MD Anderson Cancer Center, Houston.
Background:
Mucormycosis is a destructive invasive mold infection afflicting patients with diabetes and hematologic malignancies. Patients with diabetes are often treated with statins, which have been shown to have antifungal properties. We sought to examine the effects of statins on Rhizopus oryzae, a common cause of mucormycosis.
Methods:
Clinical strains of R. oryzae were exposed to lovastatin, atorvastatin, and simvastatin and the minimum inhibitory concentrations (MICs) were determined. R. oryzae germination, DNA fragmentation, susceptibility to oxidative stress, and ability to damage endothelial cells were assessed. We further investigated the impact of exposure to lovastatin on the virulence of R. oryzae
Results:
All statins had MICs of >64 µg/mL against R. oryzae Exposure of R. oryzae to statins decreased germling formation, induced DNA fragmentation, and attenuated damage to endothelial cells independently of the expression of GRP78 and CotH. Additionally, R. oryzae exposed to lovastatin showed macroscopic loss of melanin, yielded increased susceptibility to the oxidative agent peroxide, and had attenuated virulence in both fly and mouse models of mucormycosis.
Conclusions:
Exposure of R. oryzae to statins at concentrations below their MICs decreased virulence both in vitro and in vivo. Further investigation is warranted into the use of statins as adjunctive therapy in mucormycosis.
Insights
Statins show antifungal properties against Rhizopus oryzae, a cause of mucormycosis. Even at low doses, statins reduced fungal virulence in lab and animal models, suggesting potential as an adjunctive therapy.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Mucormycosis is a severe invasive mold infection.
- Patients with diabetes and hematologic malignancies are particularly vulnerable.
- Statins, commonly used for diabetes, possess known antifungal properties.
Purpose of the Study:
- To investigate the effects of statins on Rhizopus oryzae, a primary cause of mucormycosis.
- To determine if statins can inhibit R. oryzae growth and reduce its virulence.
Main Methods:
- Determined minimum inhibitory concentrations (MICs) of lovastatin, atorvastatin, and simvastatin against R. oryzae.
- Assessed R. oryzae germination, DNA fragmentation, and endothelial cell damage.
- Evaluated the impact of lovastatin on R. oryzae melanin, oxidative stress susceptibility, and virulence in fly and mouse models.
Main Results:
- Statins exhibited MICs greater than 64 µg/mL against R. oryzae.
- Statin exposure reduced R. oryzae germling formation and induced DNA fragmentation.
- Lovastatin exposure led to melanin loss, increased peroxide susceptibility, and attenuated virulence in vivo.
Conclusions:
- Statins, at sub-MIC concentrations, decreased R. oryzae virulence both in vitro and in vivo.
- Statins demonstrate potential as an adjunctive therapy for mucormycosis.
More Related Videos
09:21Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.
Published on: February 15, 2019
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Clinical Significance of Antibiotic Resistance
Fungal Group Zygomycota
Inhibitors of Viral Protein Synthesis
Lipid-Lowering Drugs: Statins and Miscellaneous Agents